Presented at CWLA National Conference
March 1, 2006
Sharon Amatetti, MPH
SAMHSA, Center for Substance Abuse Treatment
Nancy K. Young, Ph.D., Director
National Center on Substance Abuse and Child Welfare
Jay Wurscher, Director
Oregon Child Welfare Addiction Services
Part I Background and Context
Scope of the Problem
Scope of the Problem
Meth/Amphetamine Treatment Admission Rate
Per 100,000 Population Aged 12 or Older - 1993-2003
Source: Treatment Episode Data Set (TEDS)
Eastward Spread of Methamphetamine
Treatment Admissions by Primary Substance - 2003
Source: Treatment Episode Data Set (TEDS)
Impact of Increasing Methamphetamine Use
Smoked Cocaine/Crack and Meth/Amphetamine Treatment Admissions by Race/Ethnicity
| Cocaine/Crack | Meth/Amphetamine | |
| White | 35 | 65 |
| Hispanic | 7.1 | 22.2 |
| African American | 55.3 | 3.2 |
| Asian/PI | 0.9 | 5.3 |
| Native Amer/AK Native | 0.7 | 2 |
| Other | 0.9 | 2.3 |
Source: Treatment Episode Data Set (TEDS)
Meth/Amphetamine & Cocaine Treatment Admissions
According to Census Division 2003 RATE per 100,000
Source: Treatment Episode Data Set (TEDS)
Gender Differences
Source: Vaughn, C. (2003)
Self-Reported Reasons for Starting Methamphetamine Use
| Male | Female | |
| To lose weight | 9% | 37% |
| To relieve depression | 25% | 37% |
Richard Rawson, Ph.D., Presentation to SAMHSA, August 2005
Treatment Admissions Meth/Amphetamine as Primary Substance by Gender
Source: Treatment Episode Data Set (TEDS)
Meth/Amphetamine Admissions
By Gender - 2003
| All ages | 12-14 year-olds | 15-17 year-olds | |
| Male | 0.55 | 0.3 | 0.44 |
| Female | 0.45 | 0.7 | 0.56 |
Source: Treatment Episode Data Set (TEDS)
Female Treatment Admissions States with Highest % of Meth/Amphetamine as Primary Substance
Source: Treatment Episode Data Set (TEDS)
Trends in Primary Substance UseTreatment Admissions for Pregnant Females by Primary Substance 1995-2003
Source: Treatment Episode Data Set (TEDS)
Natural Rewards Elevate Dopamine Levels
Effects of Drugs on Dopamine Levels
Source: Di Chiara and Imperato
Effects of Methamphetamine Addiction
Short-Term Effects of Methamphetamine
|
PHYSICAL Heart rate Respiration Blood pressure Pupil size Sensory acuity Energy Appetite Sleep Reaction time |
PSYCHOLOGICAL Confidence Alertness Mood Sex drive Energy Talkativeness Boredom Loneliness Timidity |
Source: Judith Cohen, Ph.D., Presentation to NASADAD, June 2005
MethamphetamineChronic Physical Effects
|
|
Methamphetamine Chronic Psychological Effects
|
|
Source: Richard Rawson, Ph.D., Presentation to SAMHSA, August 2005
Cognitive Effects
Source: Simon (1999)
Cognitive Effects
Sources: Lundahl et al. (2004); Volkow et al. (2001)
Risks to Children When Parents Use Methamphetamine
Foster Care Population and Persons Who First Used Crack or Methamphetamine in Prior Year
Six Different Situations for Children
Source: Nancy Young, Ph.D., Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005
Six Different Situations for Children
Source: Nancy Young, Ph.D., Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005
Parent Uses or Abuses Meth
Risks to safety and well-being of children:
Source: Nancy Young, Ph.D., Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005
Parent Is Dependent on Meth
Risks to safety and well-being of children:
Source: Nancy Young, Ph.D., Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005
Mother Uses Meth While Pregnant
Sources: Anglin et al. (2000); Oro & Dixon, (1987); Rawson & Anglin (1999); Dixon & Bejar (1989); Smith et al. (2003); Shah (2002)
Mother Uses Meth While Pregnant
Source: Nancy Young, Ph.D., Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005
Mother Uses While Pregnant
Sources: Vega; SAMHSA, OAS, National Survey of Alcohol and Drug Use During Pregnancy, 2002 and 2003
Mother Uses While Pregnant
Shah, R. (2005, June). From NASADAD presentation
Parent "Cooks" Small Quantities of Meth
Source: Nancy Young, Ph.D., Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005
Environmental Methamphetamine Exposure and Risks
Source: Mason (2004)
Parent Involved in Trafficking
Source: Nancy Young, Ph.D., Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005
Parent Involved in Super Lab
Source: Nancy Young, Ph.D., Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005
Number of Children in Meth Labs
| 2000 | 2001 | 2002 | 2003 | |
| Number of incidents | 8,971 | 13,270 | 15,353 | 14,260 |
| Incidents with children present | 1,803 | 2,191 | 2,077 | 1,442 |
| Percent with children present | 20% | 16.5% | 13.5% | 10% |
| Children taken into protective custody | 353 | 78 | 1,026 | 724 |
4 years = 2,881; all children ~1,200,000
Source: El Paso Intelligence Center
National Alliance of Drug Endangered Children (DEC)
Multidisciplinary DEC TEAMS
DEC Team (cont.)
Treatment for Methamphetamine
CSAT’s
Methamphetamine Treatment Project
Source: Rick Rawson, Ph.D. Presentation to SAMHSA, August 2005
Matrix Model Treatment Outcomes
Similar Outcomes
Gender Differences and Implications for Treatment
Behavior Symptom Inventory (BSI)
Scores at Baseline
Source: Rick Rawson, Ph.D. Presentation to SAMHSA, August 2005
Histories of Violence among Clients Treated for Methamphetamine
Source: Cohen, J. (2003)
Prevalence of Co-Occurring Problems, and Violence and Trauma
Source: CSAT TIP 36
Gender Differences and Implications for Treatment
Gender Differences and Implications for Treatment
What Predicts Longer Abstinence?
Longer abstinence following treatment for women with:
M.L. Brecht, Ph.D., et al. (2005)
Summary
Summary
Summary
Summary
Summary
Summary
Summary
For Further Information
SAMHSA Resources
SAMHSA Resources
SAMHSA Resources
ATTC’s Introduction to Evidence-Based Treatments for Methamphetamine
NCSACW Mission
NCSACW Consortium
Recent NCSACW Products
Contact NCSACW
Part II Model Programs
Signs of Use and Warning Signs for Workers
Signs of Methamphetamine Use
and Use of Other Stimulants
Warning Signs for Workers
Source: Crowell & Webber (2001)
Other Severe Signs of Meth Use
Source: Crowell & Webber (2001)
Methamphetamine: Implications for Workers
Denial = Super-memory Imprinting
Research on Cognitive Impairments of MA addicts
"Methamphetamine: Snapshot Phenomenon"
Wurscher & Martin
Oregon’s Response
Oregon Child Welfare 1997-99
Oregon Child Welfare 2004
Current Oregon Issues
What Labs ARE NOT
Oregon METH Response
DEC - Drug Endangered Child Team Partners
DEC Collaboration Issues
CPS Requirements – On Site
Addiction Recovery Teams
Family Involvement Team
ADVANTAGES – ART & FIT
ADVANTAGES – ART & FIT
ADVANTAGES ART - FIT
Oregon Resource People
|
|
Sacramento County’s Response
Program Context
Sacramento County Prior to STARS and Dependency Drug Court
Sacramento County After STARS and Dependency Drug Court
Five Components of Sacramento County’s Comprehensive Reform
Reforms have been implemented over the past eleven years
Five Components of Sacramento County’s Comprehensive Reform
1. Comprehensive cross-system joint training
Three Levels of Training
Five Components of Sacramento County’s Comprehensive Reform
2. Substance abuse treatment system of care
Five Components of Sacramento County’s Comprehensive Reform
3. Early Intervention Specialists
Five Components of Sacramento County’s Comprehensive Reform
4. Recovery Management Specialists (STARS)
Five Components of Sacramento County’s Comprehensive Reform
5. Dependency Drug Court
Sacramento CountyDependency Drug CourtEvaluation Findings
4940 Irvine Boulevard, Suite 202
Irvine, CA 92620
714.505.3525
Fax 714.505.3626
www.cffutures.org
Parents and Children in Evaluation
| Comparison | CO YR 1 | CO YR 2 | CO YR 3 | |
| Parents =847 | 111 | 324 | 249 | 274 |
| Children =1,346 | 173 | 432 | 429 | 485 |
Total Mothers and Fathers in DDC Evaluation
Mothers 578
Fathers 210
Primary Drug Problem*
| Meth | Alcohol | Marijuana | Heroin | Cocaine/crack | Other | |
| Comparison | 41.1 | 17.9 | 21.4 | 7.1 | 12.5 | 0 |
| Court Ordered | 52.9 | 16.3 | 15 | 2.7 | 11.1 | 2 |
Percent of Mothers and Fathers by Mental Illness at Admission*
Mothers 34.8%
Fathers 10.0%
Percent of Mothers and Fathers by Treatment Modality*
| Residential | Out Patient | |
| Mothers | 30.7 | 69.3 |
| Fathers | 38.5 | 61.9 |
Treatment Admission Rates*
Comparison 50.5
Court OrderedFathers 86.4
Percent of Mothers and Fathers by Treatment Completion
| Completed | Left & Unsatisfactory Progress | |
| Mothers | 66 | 34 |
| Fathers | 71.6 | 28.4 |
24-Month Placement Outcomes*
| 12 Months | 18 Months | 24 Months | |
| Comparison | 210.8 | 266.1 | 300.7 |
| Court Ordered | 187.1 | 266.6 | 284 |
Time to Reunification
| Reunified | Adoption | Guardianship | Continued FR/FC | Long-term Placement | Other | |
| Comparison | 27.2 | 31.8 | 13.3 | 1.7 | 18.5 | 7.5 |
| CO YR 1 | 42.1 | 22.9 | 5.4 | 14.1 | 5.1 | 10.4 |
24-Month Cost Savings
$2,953,639 estimated savings in out-of-home care costs
References
Anglin, M., Burke, C., Perrochet, B., Stamper, E. & Dawud-Noursi, S. (2000). History of the methamphetamine problem. Journal of Psychoactive Drugs, 32(2), 137-141.
Brecht, M.-L., M. D. Anglin, et al. (2005). "Coerced Treatment for Methamphetamine Abuse: Differential Patient Characteristics and Outcomes." The American Journal of Drug and Alcohol Abuse 31(2): 337.
Brecht, M.L.(2004) Women and Methamphetamine: Characteristics, Treatment Outcomes. Presentation to the Center For Substance Abuse Treatment, State Systems Development Conference. August 13.
Cohen, Judith, Ph.D. Presentation to NASADAD, June 2005.
Colorado DEC. Retrieved from www.colodec.org/decpapers/Documents/DEC%20Medical%20Protocol.pdf
Crowell and Webber, 2004. Retrieved from www.drugfreeinfo.org/PDFs/strengthensupervision.pdf.
Dixon, S.D., & Bejar, R. (1989). Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: Incidence and clinical correlates. Journal of Pediatrics, 115(5 Pt 1), 770-778.
Ferguson, T. (2001). Overview of medical toxicology and potential exposures to clandestine drug laboratories in California. Paper presented to the Minnesota Department of Health.
Lundahl, L.H., Keenan, P., Schuster, C.R., & Johanson, C.E. (2004, June). Neurocognitive function in chronic high dose methamphetamine abusers following long term abstinence. Poster session presented at the 66th Annual Scientific Meeting of the College on
Problems of Drug Dependence, San Juan, Puerto Rico. Mason, A. P. 2004. Methamphetamine labs. Presented at the annual conference of the North Carolina Family-Based, Services Association.
Obert, J.L., London, E.D., & Rawson, R.A. (2002). Incorporating brain research findings into standard treatment: An example using the Matrix Model. Journal of Substance Abuse Treatment, 23(2), 107-113.
Office of Applied Studies, Substance Abuse and Mental Health Services Administration, Treatment Episode Data Set (TEDS).
Office of Applied Studies, Substance Abuse and Mental Health Services Administration, National Survey of Alcohol and Drug Use During Pregnancy, 2002 and 2003.
References
Oro, A.S., & Dixon, S.D. (1987). Perinatal cocaine and methamphetamine exposure: Maternal and neonatal correlates. Journal of Pediatrics, 571-578.
Rawson, Richard, Ph.D., Presentation to SAMHSA, August 2005.
Rawson, R., & Anglin, M.D. (1999, June). Methamphetamine: New knowledge, new treatments. Retrieved April 2004, from the UCLA Integrated Substance Abuse Programs Web site: http://www.uclaisap.org/slides/Index46/index.htm
Simon, S. (1999). Cognitive impairment in individuals currently using methamphetamine. Retrieved April 2004, from the UCLA Integrated Substance Abuse Programs Web site: http://www.uclaisap.org/slides/Index46/sld034.htm
Smith, L., Yonekura, M.L., Wallace, T., Berman, N., Kuo, J., & Berkowitz, C. (2003). Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. Journal of Developmental and Behavioral Pediatrics, 24(1):17-23.
Shah, R. (2005, June). From NASADAD presentation
Thompson, P.M., Hayashi, K.M., Simon, S.L., Geaga, J.A., Hong, M.S., Sui, Y., et al. (2004). Structural abnormalities in the brains of human subjects who use methamphetamine. Journal of Neuroscience, 24(26), 6028-6036.
Vaughn, C. (2003). Get up to speed on methamphetamine use. NCADI Reporter. Retrieved from http://www.health.org/newsroom/rep/215.aspx
Vega et al (1993), Profile of Alcohol and Drug Use During Pregnancy in California, 1992.
Volkow, N.D., Chang, L, Wang, G.J., Fowler, J.S., Leonido-Yee, M., Franceschi, D., et al. (2001b). Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. American Journal of Psychiatry, 158, 377-382.
Young, Nancy K., Ph.D. Testimony before the U.S. House of Representatives Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources, July 26, 2005.
Zickler, P. (2000). Brain imaging studies show long-term damage from methamphetamine abuse. NIDA Notes, 15(3).